Table 1.
Stage | Baseline | Supervision period | |||
---|---|---|---|---|---|
V0 | V1 | V2 | V3 | Vx | |
Item | ‐1–0 weeks | 6 weeks ± 3 days | 3 months ± 3 days | 6 months ± 3 days | Discontinued |
General information | × | ||||
Pathology Report | × | ||||
Eligibility criteria | × | ||||
Informed consent | × | ||||
FFPE samples | × | ||||
Blood samples | × | × | × | × | × |
Stool samples | × | × | |||
CRF | × | × | × | × | × |
Adverse reactions | × | × | × | × | × |
CRF, case report form; FFPE, formalin‐fixed paraffin‐embedded.